Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia (Q21132005)

From Wikidata

Jump to navigation Jump to search

scientific article

Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia

Language	Label	Description	Also known as
English	Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia	scientific article	Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia

Statements

scholarly article

0 references

Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia (English)

0 references

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Marleen Boelaert

7

object named as

Marleen Boelaert

author given names

Marleen

author last names

Boelaert

1 reference

16 August 2022

5

object named as

Shyam Sundar

author given names

Shyam

author last names

Sundar

1 reference

16 August 2022

author name string

Bart Ostyn

1

author given names

Bart

author last names

Ostyn

1 reference

16 August 2022

Epco Hasker

2

author given names

Epco

author last names

Hasker

1 reference

16 August 2022

Thomas P C Dorlo

3

author given names

Thomas P C

author last names

Dorlo

1 reference

16 August 2022

Suman Rijal

4

author given names

Suman

author last names

Rijal

1 reference

16 August 2022

Jean-Claude Dujardin

6

author given names

Jean-Claude

author last names

Dujardin

1 reference

16 August 2022

language of work or name

0 references

publication date

2014

0 references

0 references

9

0 references

e100220

0 references

6

0 references

copyright license

Creative Commons Attribution 4.0 International

18 June 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

19 March 2017

Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

19 March 2017

Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

19 March 2017

Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

19 March 2017

Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

19 March 2017

Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

19 March 2017

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

19 March 2017

Drug resistance in leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

7 April 2017

In vitro susceptibility of Leishmania donovani to miltefosine in Indian visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Sex bias in infectious disease epidemiology: patterns and processes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Retrospective Quarterly Cohort Monitoring for patients with Visceral Leishmaniasis in the Indian subcontinent: outcomes of a pilot project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Adherence to miltefosine treatment for visceral leishmaniasis under routine conditions in Nepal.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Cohort monitoring of persons with diabetes mellitus in a primary healthcare clinic for Palestine refugees in Jordan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Cohort monitoring of persons with hypertension: an illustrated example from a primary healthcare clinic for Palestine refugees in Jordan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Visceral leishmaniasis clinical management in endemic districts of India, Nepal, and bangladesh

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Optimal dosing of miltefosine in children and adults with visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Phase IV trial of miltefosine in adults and children for treatment of visceral leishmaniasis (kala-azar) in Bangladesh

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Monitoring drug effectiveness in kala-azar in Bihar, India: cost and feasibility of periodic random surveys vs. a health service-based reporting system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Sex hormones and modulation of immunity against leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Pharmacogenetics of cytochromes P450 in tropical medicine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Hormonal and immunological mechanisms mediating sex differences in parasite infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Oral miltefosine for Indian visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Sex differences in parasite infections: patterns and processes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

12 September 2017

Miltefosine in children with visceral leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

27 September 2017

An emerging peri-urban pattern of infection with Leishmania chagasi, the protozoan causing visceral leishmaniasis in northeast Brazil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

27 September 2017

Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

27 September 2017

Clinicoepidemiological study of drug resistance in Indian kala-azar

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

30 May 2018

Differences in resistance against kala-azar (Kenya strain) between males and females

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

30 May 2018

Visceral leishmaniasis unresponsive to antimonial drugs. I. Clinical and immunological studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

30 May 2018

Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0100220

21 January 2018

Visceral leishmaniasis in Somalia: prevalence of markers of infection and disease manifestations in a village in an endemic area.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0100220

21 January 2018

Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0100220

21 January 2018

A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0100220

21 January 2018

Clinical report--guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0100220

21 January 2018

Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062493

29 November 2018

Epidemiology of cutaneous leishmaniasis in Colombia: a longitudinal study of the natural history, prevalence, and incidence of infection and clinical manifestations

1 reference

https://pubmed.ncbi.nlm.nih.gov/24941345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use

1 reference

https://pubmed.ncbi.nlm.nih.gov/24941345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of age and sex on incidence of kala-azar

1 reference

https://pubmed.ncbi.nlm.nih.gov/24941345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24941345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate

1 reference

https://pubmed.ncbi.nlm.nih.gov/24941345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0100220

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2014PLoSO...9j0220O

0 references

release_ad22tfpekvbf7m3yoq56xazoj4

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21132005&oldid=1861440839"